Type 1 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 1 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-12-30Clinical Trial Update: Beta Cell Function in (Pre)Type 1 Diabetes [NA]
A clinical trial entry (NCT01402037) sponsored by Universitair Ziekenhuis Brussel investigates beta cell function in individuals with Type 1…
-
CLINICAL_TRIALS research · 2013-12-30Clinical Trial Update: Bet Cell Therapy in Diabetes Type 1 [Phase 2]
Clinical trial update for Bet Cell Therapy in Type 1 diabetes mellitus, Phase 2; the trial status is currently UNKNOWN.
-
FDA approval · 2013-12-12FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN N (insulin human) from Eli Lilly, granting a supplemental approval to the existing biolo…
-
FDA approval · 2013-12-12FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humalog Mix75/25 (insulin lispro) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: A Trial Investigating NN1218 in Subjects With Type 1 Diabetes [Phase 1]
This document reports the completion of a Phase 1 trial evaluating NN1218 in adults with Type 1 diabetes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-10Clinical Trial Update: The Effect of GLP-1 on the Inhibition of Glucagon Secretion [NA]
A completed clinical trial evaluating the effect of GLP-1 on glucagon secretion in people with Type 1 diabetes mellitus and Type 2 diabetes …
-
FDA approval · 2013-12-09FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company. This confirms regulatory approval …
-
FDA approval · 2013-12-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DM [Phase 3]
A Phase 3 randomized trial assessed the efficacy and safety of continuous glucose monitoring in children aged 4 to under 10 with Type 1 diab…
-
CLINICAL_TRIALS withdrawal · 2013-12-04Clinical Trial Update: Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes [Phase 2]
A Phase 2 study evaluating a small subcutaneous glucagon dose to treat hypoglycemia in adults with type 1 diabetes has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Subjects With Type 1 Diabetes [Phase 1]
A completed Phase 1 study comparing the effects of NN5401, NN1250, and insulin aspart in subjects with Type 1 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: A Trial Assessing Changes in Blood Sugar and the Number of Periods Where Supplementation of Carbohydrate is Needed to Treat Low Blood Sugar, During Two Different Treatment Regimens of NN1250 in Type 1 Diabetics [Phase 1]
Phase 1 study evaluating NN1250 in individuals with Type 1 diabetes, comparing two treatment regimens and assessing changes in blood glucose…
-
CLINICAL_TRIALS trial_result · 2013-11-27Clinical Trial Update: Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics [Phase 1]
Phase 1 study in type 1 diabetes comparing NN5401, NN1250, and insulin aspart; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Mobile Communication Technology for Adolescents With Diabetes [NA]
A clinical trial evaluating mobile communication technology for adolescents with Type 1 diabetes mellitus has completed. The results were po…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Interferon-Alpha for Diabetes Mellitus Type 1 [Phase 2]
Phase 2 study of interferon-alpha in type 1 diabetes mellitus has been completed.
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Mixed Meal Test in Type 1 Diabetes: Optimization of Artificial Pancreas-Pilot Study [Phase 4]
This document provides an update on a Phase 4 pilot study evaluating optimization of an artificial pancreas during a mixed-meal test in indi…
-
CLINICAL_TRIALS guidance · 2013-11-15Clinical Trial Update: Guidelines for Post-exercise Dietary Intake in T1DM [NA]
This clinical trial update from Northumbria University presents guidelines for post-exercise dietary intake for people with Type 1 Diabetes …
-
CLINICAL_TRIALS research · 2013-11-15Clinical Trial Update: Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy
Clinical trial investigating the role of the c242T polymorphism of p22phox in diabetic nephropathy among individuals with Type 1 diabetes; t…
-
CLINICAL_TRIALS research · 2013-11-13Clinical Trial Update: Genetics of Type 1 Diabetes in Chinese Adolescents and Youth
Clinical trial update on the genetics of Type 1 diabetes in Chinese adolescents and youth. The study is sponsored by Shanghai Jiao Tong Univ…
-
FDA approval · 2013-11-07FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humulin N (insulin human) from Eli Lilly and Company. This action updates the product's labe…
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: Glycaemic Load and Pre-meal Insulin Doses in Type 1 Diabetes Patients [NA]
A completed clinical trial from Federico II University examining how glycaemic load influences pre-meal insulin dosing in patients with Type…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Determination of Dosing and Frequency of BCG Administration to Alter T-Lymphocyte Profiles in Type I Diabetics [Phase 1]
This Phase 1 trial evaluates how dosing and frequency of Bacillus Calmette-Guérin (BCG) administration affect T-lymphocyte profiles in indiv…
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: The Effect of Supplementation With Two Different Doses of Vitamin D on Bone Mineral Density, Vitamin D Levels and Hand Grip Strength in Children With Diabetes Mellitus Type 1 [Phase 4]
A Phase 4 clinical trial completed to evaluate the effects of two doses of vitamin D on bone mineral density, vitamin D levels, and hand gri…
-
FDA approval · 2013-10-31FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a supplemental application for LEVEMIR (insulin detemir) submitted by Novo Nordisk.
-
CLINICAL_TRIALS trial_result · 2013-10-29Clinical Trial Update: Safety and Tolerability of Oshadi Icp In Patients With Type 1 Diabetes Mellitus - Phase Ib Clinical Study [Phase 1, Phase 2]
A completed Phase Ib/Phase II clinical trial update evaluating the safety and tolerability of Oshadi Icp in patients with Type 1 diabetes me…